Independent, AI-assisted research · Affiliate disclosure
Salt Cave Finder
article

Halotherapy Research: The Latest Clinical Studies in 2026

By Jennifer Coleman · Wellness Journalist & Editor, Salt Cave Finder

Updated May 2026

March 23, 2026 · 5 min read

Quick Answer

  • 2025 Springer Nature study found halotherapy improved acute respiratory distress prognosis
  • 2021 PMC systematic review backs salt therapy as adjunct asthma care
  • Active pediatric asthma trial NCT06250452 on ClinicalTrials.gov
  • Evidence supports sinusitis, bronchitis, COPD, and mild-moderate asthma only

The scientific evidence for halotherapy has grown over the last decade, moving from Eastern European folk medicine into peer-reviewed clinical research. The body of work is still small, but it's no longer absent.

This guide summarizes the current state of halotherapy research as of 2026. The goal is to separate what the studies actually show from what marketing copy claims.

Medical note: Halotherapy is complementary, not curative. Nothing in this article replaces a diagnosis or treatment plan from a licensed clinician.

Major Studies and Reviews

2025: Halotherapy and Acute Respiratory Distress Syndrome

Published in Discover Medicine (Springer Nature), this study extended halotherapy research into acute care (Discover Medicine, 2025).

Conducted from January 2022 to January 2024, the team found halotherapy improved the prognosis of acute respiratory distress syndrome.

The study reported reduced pyroptosis-related biomarkers — indicators of inflammatory cell death. That's a mechanistic finding, not just symptom reporting.

Significance: it moves halotherapy beyond chronic conditions and into acute respiratory care for the first time at this level of publication.

2021: Comprehensive Asthma Review

Published in the International Journal of Environmental Research and Public Health, this review pulled all available studies on halotherapy for asthma (Rashleigh et al., 2021, IJERPH via PMC).

Title: "Halotherapy — An Ancient Natural Ally in the Management of Asthma."

The conclusion: all studies sustained positive effects as adjuvant therapy with no reported adverse events.

The authors called for further evidence-based studies on larger populations. Current sample sizes remain small.

2020: Halotherapy for Chronic Respiratory Disorders

Published in Complementary Therapies in Medicine (Zajac et al., 2020, PubMed).

Title: "Halotherapy for Chronic Respiratory Disorders: From the Cave to the Clinical."

Findings: halotherapy has positive effects on mucociliary clearance and lung function. No official guidelines exist, but evidence supports adjuvant use.

The authors drew a sharp line between therapeutic halotherapy with calibrated halogenerators and decorative salt rooms with no aerosol delivery. The distinction matters for outcomes.

2017: Halotherapy in Children with Asthma

Published in Pediatric Pulmonology — a randomized, controlled, prospective pilot study (Bar-Yoseph et al., 2017, PubMed).

The team studied halotherapy as asthma treatment in children. Improvements were found in bronchial responsiveness and quality of life.

Small sample size was noted as a limitation. The authors recommended larger trials.

2014: Chronic Allergic Respiratory Conditions

Published in the Journal of Medicine and Life (Chervinskaya, 2014, JML via PMC).

This study surveyed therapeutic effects of halotherapy on chronic allergic respiratory pathologies.

It documented anti-inflammatory and anti-allergic mechanisms. Participants showed symptom improvement in bronchial asthma, chronic bronchitis, and COPD. Patients with infectious-inflammatory pathologies were also included.

Ongoing: ClinicalTrials.gov NCT06250452

Currently studying the effect of halotherapy chambers on (ClinicalTrials.gov, 2024):

  • Bronchial hyper-responsiveness
  • Fractional exhaled nitric oxide
  • Quality of life in children with asthma

Results are expected to provide stronger evidence for pediatric applications. This is the trial worth watching for the next major data point.

2023: Cochrane-Adjacent Review on COPD

A 2023 systematic review in the European Respiratory Journal looked at salt therapy for COPD specifically (Beamon et al., 2023, ERJ). It echoed the same evidence gap — promising signal, too few randomized controlled trials to recommend at clinical guideline level.

What the Evidence Supports

Strong Evidence (Multiple Studies)

  • Improvement in sinusitis symptoms
  • Improved mucociliary clearance
  • Reduced symptoms in mild-moderate asthma as adjuvant therapy
  • Symptom relief in chronic bronchitis
  • No adverse events reported across all studies

Moderate Evidence (Limited Studies)

  • Skin condition improvement in eczema and psoriasis
  • COPD symptom management
  • Improved spirometry parameters
  • Anti-inflammatory effects in bronchial tissue

Emerging Evidence (Preliminary)

Insufficient Evidence

  • Cancer treatment or prevention
  • Weight loss
  • Detoxification claims
  • Immune system "boosting"

Anyone marketing halotherapy for these uses is ahead of the data.

Research Gaps and Limitations

The field has real constraints that responsible readers should know.

Sample sizes: Most studies use small cohorts of 20-100 participants. That's pilot-trial territory.

Standardization: No standardized halogenerator settings or protocols across studies. Particle size, concentration, and session duration vary widely.

Placebo control: Blinding is difficult — participants know when they're in a salt cave. Sham conditions are an open methodological problem.

Long-term outcomes: Most studies measure short-term effects in weeks or months. Sustained-benefit data is thin.

Mechanism clarity: The exact cellular and molecular pathways need further elucidation. We have hypotheses, not confirmed mechanisms.

The Market Context

The growing evidence base is fueling market expansion regardless of the gaps:

  • Global salt therapy market hit $7.87 billion in 2024, projected $19.05 billion by 2034 (Precedence Research, 2025)
  • Clinical trials on ClinicalTrials.gov signal regulatory and academic interest
  • The Springer Nature publication (2025) represents high-impact journal validation
  • Healthcare integration depends on continued positive research outcomes

The gap between consumer demand and clinical evidence is the central tension in this niche.

Frequently Asked Questions

Is halotherapy scientifically proven?

Halotherapy has a growing evidence base with multiple clinical studies showing positive results for respiratory conditions. The 2021 PMC comprehensive review found consistently positive outcomes for asthma management with no adverse events. But the evidence base is smaller than for conventional pharmaceutical treatments, and large-scale randomized controlled trials are still needed. The current consensus: halotherapy is a promising complementary therapy supported by moderate evidence.

What conditions has halotherapy been clinically studied for?

Clinical studies have examined halotherapy for sinusitis, chronic bronchitis, bronchiectasis, mild-moderate asthma, COPD, acute respiratory distress syndrome, allergic rhinitis, and skin conditions like eczema and psoriasis. The strongest evidence exists for sinusitis, chronic bronchitis, and mild-moderate asthma per Zajac et al. (2020).

Are there any side effects reported in halotherapy studies?

No adverse events have been reported in published halotherapy studies. The 2021 PMC review specifically noted no reported adverse events across all reviewed studies. Mild salt taste and temporary minor cough from mucus loosening are common but not classified as adverse events.

Where is halotherapy research heading?

Active research areas include pediatric asthma (NCT06250452), acute respiratory conditions building on the 2025 Springer Nature study, post-COVID respiratory rehabilitation, and mechanism-level studies using modern molecular biology tools. Larger multi-center RCTs are the most critical next step.

Should I trust halotherapy claims based on current research?

Trust claims that align with the evidence — respiratory symptom improvement, mucociliary clearance, and anti-inflammatory effects as complementary therapy. Be skeptical of claims that halotherapy cures serious disease, replaces medications, or delivers dramatic transformations. The evidence supports halotherapy as a helpful adjuvant, not a miracle cure.


Related Reading

-- The Salt Cave Finder Team

Find a Cave

What brings you to salt therapy?

Related Articles

Stay in the loop

Get the latest articles delivered to your inbox.